Overview

Alzheimer's Disease Prevention Trial

Status:
Completed

Trial end date:
2007-09-01

Target enrollment:

Participant gender:

Summary

This is a three-year study to determine if estrogens can prevent memory loss and Alzheimer's disease in women with a family history of Alzheimer's disease.

Phase:

Phase 3

Details

Lead Sponsor:

National Institute on Aging (NIA)

Treatments:

Estrogens
Progesterone